Clinical Trial

A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

Study acronym: RENEW-COPD
Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The main purpose of this study is to assess if different dose levels of Brenipatide are safe and work the way they are intended to work in participants with moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD), when compared with placebo. The study will last approximately one year.
Trial Details
NCT Number NCT07759245
Lead Sponsor Eli Lilly and Company
Conditions Pulmonary Disease, Chronic Obstructive
Enrollment 606 participants
Start Date 2026-08
Primary Completion 2028-05 (estimated)
Study Completion 2028-11 (estimated)
Updated on ClinicalTrials.gov 2026-08-12